Literature DB >> 11746426

Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease.

S R Robinson1.   

Abstract

The intracellular localization of glutamine synthetase (GS) in the inferior temporal cortices of non-demented elderly individuals was compared with that in brains affected by Alzheimer's disease (AD). The present study confirmed previous reports of a general decrease in GS expression in astrocytes and the expression of GS in some neurons. Several new observations were made: the morphology of astrocytes is generally unaffected by the presence of plaques, GS labeling is present in some diffuse plaques and occasional neuritic plaques, whereas the overall density of astrocytes increases 1.4-fold in AD. In addition, the present study found that the reduction in GS expression is almost entirely due to a loss of GS from perisynaptic regions of the neuropil and from the astrocytic endfeet that normally abut cortical blood vessels. These changes implicate astrocytes in glutamate excitotoxicity and ammonia neurotoxicity. It is suggested that it may be more fruitful to regard AD not as a neuronal disease, but as a disorder of astrocyte-neuron interactions. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746426     DOI: 10.1002/jnr.10057

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  34 in total

1.  Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.

Authors:  Alexander P Lin; Frederick Shic; Cathleen Enriquez; Brian D Ross
Journal:  MAGMA       Date:  2003-02       Impact factor: 2.310

2.  SIV-Induced Immune Activation and Metabolic Alterations in the Dorsal Root Ganglia During Acute Infection.

Authors:  Lisa M Mangus; Rachel L Weinberg; Audrey C Knight; Suzanne E Queen; Robert J Adams; Joseph L Mankowski
Journal:  J Neuropathol Exp Neurol       Date:  2019-01-01       Impact factor: 3.685

3.  Proteomics analysis of human brain tissue infected by street rabies virus.

Authors:  Firouzeh Farahtaj; Fatemeh Zandi; Vahid Khalaj; Peyvand Biglari; Ahmad Fayaz; Behrouz Vaziri
Journal:  Mol Biol Rep       Date:  2013-09-24       Impact factor: 2.316

Review 4.  From Molecular Circuit Dysfunction to Disease: Case Studies in Epilepsy, Traumatic Brain Injury, and Alzheimer's Disease.

Authors:  Chris G Dulla; Douglas A Coulter; Jokubas Ziburkus
Journal:  Neuroscientist       Date:  2015-05-06       Impact factor: 7.519

5.  The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats.

Authors:  Ana Carolina Tramontina; Krista Minéia Wartchow; Letícia Rodrigues; Regina Biasibetti; André Quincozes-Santos; Larissa Bobermin; Francine Tramontina; Carlos-Alberto Gonçalves
Journal:  J Neural Transm (Vienna)       Date:  2011-07-10       Impact factor: 3.575

6.  TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease.

Authors:  M M Edwards; S R Robinson
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

7.  Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Malia M Edwards; José J Rodríguez; Raquel Gutierrez-Lanza; Joseph Yates; Alexei Verkhratsky; Gerard A Lutty
Journal:  Exp Eye Res       Date:  2014-08-19       Impact factor: 3.467

8.  Synaptic protein expression is regulated by a pro-oxidant diet in APPxPS1 mice.

Authors:  Martin Broadstock; Rikke Lewinsky; Emma L Jones; Cathy Mitchelmore; David R Howlett; Paul T Francis
Journal:  J Neural Transm (Vienna)       Date:  2011-11-05       Impact factor: 3.575

9.  High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease.

Authors:  Tommaso Nuzzo; Andrea Mancini; Mattia Miroballo; Alessia Casamassa; Anna Di Maio; Giorgia Donati; Giulia Sansone; Lorenzo Gaetani; Federico Paolini Paoletti; Andrea Isidori; Paolo Calabresi; Francesco Errico; Lucilla Parnetti; Alessandro Usiello
Journal:  Amino Acids       Date:  2021-02-22       Impact factor: 3.520

Review 10.  Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.

Authors:  Alison E Mungenast; Sandra Siegert; Li-Huei Tsai
Journal:  Mol Cell Neurosci       Date:  2015-12-04       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.